跳至主要内容
临床试验/DRKS00030537
DRKS00030537招募中未知

Randomized investigator-blinded crossover study of the efficacy of XyliMelts adhesive tablets for symptomatic relief of nocturnal dry mouth in patients with dry mouth after head and neck irradiation

Quest Products, LLC0 个研究点目标入组 32 人开始时间: 2022年10月18日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Minimum age: 18
  • - Ability to consent to study participation.
  • - Written informed consent
  • - Patients from the dental group practice of Dr. Dirheimer and Dr. Ludwig Ulm, Germany.
  • - Subjective xerostomia: at least 6 on a VAS scale of 1 to 10 after waking AND at least 6 weeks of radiation therapy due to tumor disease in the head and neck region
  • - Primary therapy at least 6 months, maximum 18 months ago

排除标准

  • - Existing or planned pregnancy during the study
  • - Current radiotherapy/chemotherapy or antibody therapy
  • - Acute inflammatory oral disease/abscess
  • - Change in medication with possible influence on salivary flow rates during the study

研究者

发起方
Quest Products, LLC

相似试验